Patent 8926691 was granted and assigned to Edwards Lifesciences on January, 2015 by the United States Patent and Trademark Office.
Embodiments of an apparatus for treating a deficient mitral valve include an expandable spacer configured for placement between the native leaflets of the mitral valve, the spacer anchorable to a wall of the ventricle. Methods and apparatus for delivering and implanting the prosthetic are also described.